Premium
Rifampicin Treatment of Cutaneous Leishmaniasis
Author(s) -
EvenPaz Zvi,
Weinrauch Louis,
Livshin Rita,
ElOn Joseph,
Leonard Greenblatt Charles
Publication year - 1982
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4362.1982.tb00517.x
Subject(s) - rifampicin , medicine , leishmaniasis , cutaneous leishmaniasis , leishmania , miltefosine , dermatology , pharmacology , immunology , visceral leishmaniasis , pathology , tuberculosis , parasite hosting , world wide web , computer science
In a small‐scale preliminary trial of oral rifampicin treatment was considered successful in six out of eight cutaneous leishmaniasis patients and probably effective in a seventh. The in vitro effect of rifampicin on leishmania organisms concerns inhibition of mitochondrial function or replication. The need for protozoological control in the assessment of treatment is stressed.